| Financial Year |
March 31 2023 |
| Monetary Funds |
1,751,294,153.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
866,903,067.65 |
| Advances to Suppliers |
33,824,534.70 |
| Other Receivables |
44,039,176.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,576,119.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,379,579.29 |
| Total Current Assets |
2,833,932,137.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,076,356.73 |
| Long-term Equity Investment |
414,913,679.93 |
| Investment Properties |
102,119,969.78 |
| Fixed Assetes |
216,988,849.64 |
| Under-construction Projects |
11,869,906.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,196,489.29 |
| R&D expenses |
106,229,441.30 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,194,890.33 |
| Deferred Income Tax Assets |
3,056,392.84 |
| Other Non-Current Assets |
18,302,774.27 |
| Sub-Total of Non-Current Assets |
1,180,560,102.29 |
| Total Assets |
4,014,492,239.99 |
| Short-Term Loans |
1,542,895,678.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
173,388,696.10 |
| Accounts Received In Advance |
1,938,336.88 |
| Employee Compensation Payable |
12,269,076.42 |
| Taxes Payable |
31,762,990.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
129,020,141.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,508,273.31 |
| Other Current Liabilities |
1,329,060.70 |
| Sub-Total of Current Liabilities |
1,965,843,729.82 |
| Long-term Loans |
135,202,125.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
48,217,760.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,892,341.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
194,415,344.80 |
| Total Liabilities |
2,160,259,074.62 |
| Paid-In Capital(Or Share Stock) |
712,323,832.00 |
| Capital Surplus |
1,407,634,367.71 |
| Surplus Reserve |
118,306,693.75 |
| LESS:Treasury Stock |
14,785,230.79 |
| Undistributed Profits |
-388,487,460.35 |
| Minority Stockholder's Interest |
19,290,795.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,834,942,370.34 |
| Owner's Equity（Stockholder's Equity） |
1,854,233,165.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,014,492,239.99 |
